tradingkey.logo

Boundless Bio Inc

BOLD
1.220USD
-0.050-3.94%
Close 12/19, 16:00ETQuotes delayed by 15 min
27.31MMarket Cap
LossP/E TTM
You can access the annual and quarterly cash flow statements of Boundless Bio Inc to evaluate its financial soundness and stability.
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
Operating cash flows (indirect method)
Cash flow from continuing operating activities
23.15%-10.20M
27.14%-11.83M
7.90%-14.53M
-33.18%-15.56M
-8.84%-13.27M
-49.09%-16.24M
-30.49%-15.78M
-14.76%-11.69M
-12.86%-12.19M
---10.89M
---12.09M
---10.18M
---10.80M
Net income from continuing operations
15.93%-13.88M
7.66%-15.68M
-2.13%-15.76M
-35.44%-16.45M
-25.32%-16.51M
-36.93%-16.98M
-31.67%-15.43M
-3.10%-12.14M
-0.37%-13.17M
---12.40M
---11.72M
---11.78M
---13.13M
Operating gains losses
18.32%310.00K
19.62%317.00K
20.53%317.00K
19.84%296.00K
11.49%262.00K
11.34%265.00K
10.97%263.00K
3.35%247.00K
-4.47%235.00K
--238.00K
--237.00K
--239.00K
--246.00K
Other non-cash items
132.84%224.00K
111.65%125.00K
111.58%41.00K
43.65%-293.00K
-0.59%-682.00K
-579.11%-1.07M
-180.27%-354.00K
-201.56%-520.00K
-184.86%-678.00K
---158.00K
--441.00K
--512.00K
--799.00K
Change in working capital
14.15%1.85M
391.48%1.71M
41.44%-927.00K
-525.56%-1.13M
197.43%1.62M
-217.17%-587.00K
4.87%-1.58M
-171.15%-180.00K
-20.47%544.00K
--501.00K
---1.66M
--253.00K
--684.00K
-Change in prepaid expenses
-104.91%-27.00K
63.07%-424.00K
130.53%214.00K
1045.98%997.00K
58.96%550.00K
-833.33%-1.15M
-211.56%-701.00K
-64.05%87.00K
38.96%346.00K
---123.00K
---225.00K
--242.00K
--249.00K
-Change in payables and accrued expense
-13.62%1.54M
-3.85%1.20M
-891.90%-2.08M
-472.68%-2.05M
108.65%1.78M
7.22%1.25M
76.77%-210.00K
-1.08%549.00K
62.55%855.00K
--1.16M
---904.00K
--555.00K
--526.00K
Cash from non-recurring investing activities
Cash from operating activities
23.15%-10.20M
27.14%-11.83M
7.90%-14.53M
-33.18%-15.56M
-8.84%-13.27M
-49.09%-16.24M
-30.49%-15.78M
-14.76%-11.69M
-12.86%-12.19M
---10.89M
---12.09M
---10.18M
---10.80M
Investing cash flow
Net cash from continuing investing activities
-96.89%15.00K
-96.81%48.00K
-28.92%59.00K
73.88%466.00K
219.87%483.00K
1075.00%1.50M
-3.49%83.00K
587.18%268.00K
32.46%151.00K
--128.00K
--86.00K
--39.00K
--114.00K
Capital expenditures
-96.89%15.00K
-96.81%48.00K
-28.92%59.00K
73.88%466.00K
219.87%483.00K
1075.00%1.50M
-3.49%83.00K
587.18%268.00K
32.46%151.00K
--128.00K
--86.00K
--39.00K
--114.00K
Net cash flow from disposal of fixed assets
-96.89%15.00K
-96.81%48.00K
-28.92%59.00K
73.88%466.00K
219.87%483.00K
1075.00%1.50M
-3.49%83.00K
587.18%268.00K
32.46%151.00K
--128.00K
--86.00K
--39.00K
--114.00K
Net cash flow from investment products
-53.60%10.49M
117.00%11.34M
-82.88%3.12M
-85.76%2.29M
398.88%22.61M
2.49%-66.69M
-18.12%18.22M
91.36%16.08M
-187.47%-7.57M
---68.39M
--22.25M
--8.40M
--8.65M
Cash from non-current investing activities
Net cash flow from investing activities
-52.65%10.48M
116.56%11.29M
-83.13%3.06M
-88.47%1.82M
386.77%22.13M
0.48%-68.19M
-18.18%18.14M
89.05%15.81M
-190.41%-7.72M
---68.52M
--22.17M
--8.36M
--8.54M
Financing cash flow
Cash flow from continuous financing activities
100.00%0.00
-99.87%117.00K
100.00%0.00
108.16%113.00K
97.09%-13.00K
-9.08%90.65M
-3080.65%-924.00K
-4054.29%-1.38M
-1115.91%-447.00K
--99.70M
--31.00K
--35.00K
--44.00K
Net cash flow from common stock issuance/repurchase
100.00%0.00
-99.87%117.00K
----
--110.00K
---13.00K
--89.66M
----
----
----
----
----
----
----
Net cash flow from preferred stock issuance/repurchase
----
----
----
----
----
----
----
--0.00
--0.00
--99.67M
----
--0.00
--0.00
Proceeds from stock option exercised by employees
----
----
----
-92.31%3.00K
-100.00%0.00
-100.00%0.00
90.32%59.00K
11.43%39.00K
95.45%86.00K
--26.00K
--31.00K
--35.00K
--44.00K
Net cash flow from other financing activities
----
----
----
----
----
--983.00K
---983.00K
---1.42M
---533.00K
----
--0.00
--0.00
----
Net cash from non-recurrent financing activities
Net cash from financing activities
100.00%0.00
-99.87%117.00K
100.00%0.00
108.16%113.00K
97.09%-13.00K
-9.08%90.65M
-3080.65%-924.00K
-4054.29%-1.38M
-1115.91%-447.00K
--99.70M
--31.00K
--35.00K
--44.00K
Net cash flow
Beginning cash balance
-52.21%15.26M
-39.01%15.68M
11.87%27.15M
89.44%40.77M
-23.77%31.92M
19.04%25.70M
111.30%24.27M
62.22%21.52M
170.38%41.88M
--21.59M
--11.48M
--13.27M
--15.49M
Current period cash flow changes
-96.80%283.00K
-106.75%-420.00K
-898.19%-11.47M
-596.97%-13.63M
143.49%8.85M
-69.34%6.22M
-85.78%1.44M
253.70%2.74M
-816.80%-20.35M
--20.29M
--10.11M
---1.78M
---2.22M
Ending cash balance
-61.89%15.54M
-52.21%15.26M
-39.01%15.68M
11.87%27.15M
89.44%40.77M
-23.77%31.92M
19.04%25.70M
111.30%24.27M
62.22%21.52M
--41.88M
--21.59M
--11.48M
--13.27M
Free cash flow
25.74%-10.21M
33.05%-11.88M
8.01%-14.59M
-34.09%-16.03M
-11.42%-13.75M
-61.01%-17.74M
-30.25%-15.86M
-16.94%-11.95M
-13.07%-12.34M
---11.02M
---12.18M
---10.22M
---10.91M
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
--

FAQs

What is the cash flow statement?

This report tracks the movement of cash into and out of the business, covering operating, investing, and financing activities. It highlights how well the company manages cash to support growth and meet its obligations.
KeyAI